Regulations.gov document
Attachment 2 - Vancomycin Hydrochloride for Injection, USP RE Suitability Petition from…
Supporting & Related Material · FDA-2023-P-4334 · posted Oct 4, 2023
Key facts
| Document ID | FDA-2023-P-4334-0004 |
|---|---|
| Title | Attachment 2 - Vancomycin Hydrochloride for Injection, USP RE Suitability Petition from Hospira, Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-P-4334 |
| Posted | Oct 4, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: